scholarly journals Surgical correction of respiratory failure in patients with diffuse pulmonary emphysema who underwent long-term oxygen therapy

2017 ◽  
Vol 176 (4) ◽  
pp. 71-74
Author(s):  
S. D. Gorbunkov ◽  
V. V. Varlamov ◽  
S. M. Chernyi ◽  
Z. A. Zaripova ◽  
A. Yu. Gichkin ◽  
...  

OBJECTIVE. The research showed the possibility of operative treatment of patients with terminal stage of respiratory failure who underwent long-term oxygen therapy. MATERIAL AND METHODS. Surgical correction of respiratory failure was performed for two patients after clinical, functional and radio studies. RESULTS. The degree of arterial hypoxemia significantly decreased after operation due to improved ventilation of maximally saved pulmonary tissue areas. This allowed doctors to apply a situational oxygen therapy. Tolerance of physical activity reliably improved and value of BODE-index decreased. CONCLUSIONS. The terminal stage of respiratory failure couldn’t be a contraindication to surgical treatment.

2018 ◽  
Vol 44 (5) ◽  
pp. 390-397 ◽  
Author(s):  
Carolina Bonfanti Mesquita ◽  
Caroline Knaut ◽  
Laura Miranda de Oliveira Caram ◽  
Renata Ferrari ◽  
Silmeia Garcia Zanati Bazan ◽  
...  

ABSTRACT Objective: To determine the impact of adherence to long-term oxygen therapy (LTOT) on quality of life, dyspnea, and exercise capacity in patients with COPD and exertional hypoxemia followed for one year. Methods: Patients experiencing severe hypoxemia during a six-minute walk test (6MWT) performed while breathing room air but not at rest were included in the study. At baseline and after one year of follow-up, all patients were assessed for comorbidities, body composition, SpO2, and dyspnea, as well as for anxiety and depression, having also undergone spirometry, arterial blood gas analysis, and the 6MWT with supplemental oxygen. The Saint George’s Respiratory Questionnaire (SGRQ) was used in order to assess quality of life, and the Body mass index, airflow Obstruction, Dyspnea, and Exercise capacity (BODE) index was calculated. The frequency of exacerbations and the mortality rate were noted. Treatment nonadherence was defined as LTOT use for < 12 h per day or no LTOT use during exercise. Results: A total of 60 patients with COPD and exertional hypoxemia were included in the study. Of those, 10 died and 11 experienced severe hypoxemia during follow-up, 39 patients therefore being included in the final analysis. Of those, only 18 (46.1%) were adherent to LTOT, showing better SGRQ scores, higher SpO2 values, and lower PaCO2 values than did nonadherent patients. In all patients, SaO2, the six-minute walk distance, and the BODE index worsened after one year. There were no differences between the proportions of adherence to LTOT at 3 and 12 months of follow-up. Conclusions: Quality of life appears to be lower in patients with COPD and exertional hypoxemia who do not adhere to LTOT than in those who do. In addition, LTOT appears to have a beneficial effect on COPD symptoms (as assessed by SGRQ scores). (Brazilian Registry of Clinical Trials - ReBEC; identification number RBR-9b4v63 [http://www.ensaiosclinicos.gov.br])


Respiration ◽  
2002 ◽  
Vol 69 (2) ◽  
pp. 117-122 ◽  
Author(s):  
Margherita Sergi ◽  
Maurizio Rizzi ◽  
Arnaldo Andreoli ◽  
Marica Pecis ◽  
Claudio Bruschi ◽  
...  

2021 ◽  
Vol 5 (4) ◽  
pp. 199-206
Author(s):  
Naomi Kayauchi ◽  
Eiji Ojima ◽  
Katsunori Kagohashi ◽  
Hiroaki Satoh

Purpose: To investigate the long-term changes in body weight and serum albumin levels in patients with respiratory failure, and those with chronic heart failure, who were treated with home long-term oxygen therapy (LTOT) to understand the current status and contribute to future measures. Methods: Patients with chronic obstructive pulmonary disease (COPD), those with interstitial pneumonia (IP), and those with chronic heart failure (CHF) undergoing home LTOT for 6 months or more between January 2011 and January 2019 were included in the study. Body weight and serum albumin levels were assessed at the start of home LTOT and at the end of the observation period, a minimum of 6 months after commencing home LTOT. Results: Sixty-two patients (29 COPDs, 23 IPs, and 10 CHFs) were included. In COPD patients and IP patients, body weight decreased (P = 0.0017, P = 0.0018, respectively, Wilcoxon signed-rank test). Serum albumin levels decreased in IP patients (P = 0.0185) but not in COPD patients. There was neither significant decrease in body weight nor serum albumin levels in patients with CHF. Conclusion: Chronic respiratory failure patients who have home LTOT were likely to have a decreased nutritional status. In order to provide prolonged home LTOT, medical staff need to pay close attention to the nutritional status of patients receiving home LTOT.


2014 ◽  
Vol 62 (9) ◽  
pp. 1807-1808 ◽  
Author(s):  
Hiroo Wada ◽  
Yoko Akiyama ◽  
Hirotaka Takeda ◽  
Masuo Nakamura ◽  
Hajime Takizawa

Sign in / Sign up

Export Citation Format

Share Document